2024 Australia –New Zealand Expert Consensus Statement on Cardiac Amyloidosis

Over the past 5 years, early diagnosis of and new treatments for cardiac amyloidosis (CA) have emerged that hold promise for early intervention. These include non-invasive diagnostic tests and disease modifying therapies. Recently, CA has been one of the first types of cardiomyopathy to be treated with gene editing techniques. Although these therapies are not yet widely available to patients in Australia and New Zealand, this may change in the near future. Given the rapid pace with which this field is evolving, it is important to view these advances within the Australian and New Zealand context.

Source: Heart, Lung and Circulation - April 2, 2024 Category: Cardiology Authors: Nicole K. Bart, Diane Fatkin, James Gunton, James L. Hare, Dariusz Korczyk, Fiona Kwok, Kaitlyn Lam, David Russell, Hasib Sidiqi, Tim Sutton, Simon D.J. Gibbs, Peter Mollee, Liza Thomas Tags: Consensus Statement Source Type: research